Skip to main content
. 2020 Oct 15;30(4):426–434. doi: 10.1002/pds.5124

FIGURE 3.

FIGURE 3

Incidence of patients with NVAF newly prescribed a NOAC per 10 000 persons, by study year. Data for 2017 were from January to December inclusive. Data are from two clinical benefit providers (Salud Total and Compensar). NOAC, non‐vitamin K antagonist oral anticoagulant; NVAF, nonvalvular atrial fibrillation [Colour figure can be viewed at wileyonlinelibrary.com]